Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neuroblastoma.
Chung C, Boterberg T, Lucas J, Panoff J, Valteau-Couanet D, Hero B, Bagatell R, Hill-Kayser CE. Chung C, et al. Among authors: boterberg t. Pediatr Blood Cancer. 2021 May;68 Suppl 2(Suppl 2):e28473. doi: 10.1002/pbc.28473. Pediatr Blood Cancer. 2021. PMID: 33818884 Free PMC article. Review.
Central nervous system relapse in high-risk stage 4 neuroblastoma: The HR-NBL1/SIOPEN trial experience.
Berlanga P, Pasqualini C, Pötschger U, Sangüesa C, Castellani MR, Cañete A, Luksch R, Elliot M, Schreier G, Kropf M, Morgenstern D, Papadakis V, Ash S, Ruud E, Brock P, Wieczorek A, Kogner P, Trahair T, Ambros P, Boterberg T, Castel V, Valteau-Couanet D, Ladenstein R. Berlanga P, et al. Among authors: boterberg t. Eur J Cancer. 2021 Feb;144:1-8. doi: 10.1016/j.ejca.2020.10.020. Epub 2020 Dec 11. Eur J Cancer. 2021. PMID: 33316634 Free article. Clinical Trial.
Results of a quality assurance review of external beam radiation therapy in the International Society of Paediatric Oncology (Europe) Neuroblastoma Group's High-risk Neuroblastoma Trial: a SIOPEN study.
Gaze MN, Boterberg T, Dieckmann K, Hörmann M, Gains JE, Sullivan KP, Ladenstein R. Gaze MN, et al. Among authors: boterberg t. Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):170-4. doi: 10.1016/j.ijrobp.2012.05.004. Epub 2012 Jun 30. Int J Radiat Oncol Biol Phys. 2013. PMID: 22749633 Clinical Trial.
Successful strategy to treat a solitary cystic melanoma brain metastasis.
Kruse V, Boterberg T, Acou M, Creytens D, Van den Broecke C, Brochez L, Hallaert G. Kruse V, et al. Among authors: boterberg t. J Eur Acad Dermatol Venereol. 2017 Apr;31(4):e216-e217. doi: 10.1111/jdv.13981. Epub 2016 Oct 12. J Eur Acad Dermatol Venereol. 2017. PMID: 27684056 No abstract available.
Global pediatric radiation therapy in resource-limited settings.
Hess CB, Parkes J, Janssens GO, Lin C, Wong K, Zaghloul MS, Marconi DG, Boterberg T, Esiashvili N. Hess CB, et al. Among authors: boterberg t. Pediatr Blood Cancer. 2021 May;68 Suppl 2:e28299. doi: 10.1002/pbc.28299. Epub 2020 Aug 2. Pediatr Blood Cancer. 2021. PMID: 32743983 Review.
Overcoming inter-observer planning variability in target volume contouring and dose planning for high-risk neuroblastoma - a European multicenter effort of the SIOPEN radiotherapy committee.
Jazmati D, Brualla L, Littooij AS, Webber B, Dieckmann K, Janssens GO, Simon T, Gaze MN, Merta J, Serrano A, Dietzsch S, Kramer PH, Wulff J, Boterberg T, Timmermann B. Jazmati D, et al. Among authors: boterberg t. Radiother Oncol. 2023 Apr;181:109464. doi: 10.1016/j.radonc.2023.109464. Epub 2023 Jan 11. Radiother Oncol. 2023. PMID: 36640946 Clinical Trial.
Weak MGMT gene promoter methylation confers a clinically significant survival benefit in patients with newly diagnosed glioblastoma: a retrospective cohort study.
Pinson H, Hallaert G, Van der Meulen J, Dedeurwaerdere F, Vanhauwaert D, Van den Broecke C, Van Dorpe J, Van Roost D, Kalala JP, Boterberg T. Pinson H, et al. Among authors: boterberg t. J Neurooncol. 2020 Jan;146(1):55-62. doi: 10.1007/s11060-019-03334-5. Epub 2019 Nov 7. J Neurooncol. 2020. PMID: 31701343
154 results